Renal Transplant Acute Rejection with Lower Mycophenolate Mofetil Dosing and Proton Pump Inhibitors or Histamine ‐2 Receptor Antagonists

ConclusionDespite taking lower MMF doses than previously studied, subjects on a PPI compared to an H2RA were not at increased risk of acute rejection within 1‐year post‐transplant.This article is protected by copyright. All rights reserved.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - October 4, 2017 Category: Drugs & Pharmacology Authors: Kajal S. Patel, Brian R. Stephany, Julie F. Barnes, Seth R. Bauer, Michael L. Spinner Tags: Original Research Article Source Type: research